Hemophilia Treatment Market: Recent Trends, Industry Segments, Trends, Competitive Landscape and Regional Forecast To 2023
Dec 13, 2018
Market Research Future (MRFR) Announces the publication of its research report – Global Hemophilia Treatment Market. By Type, By Treatment, End User – Global Forecast Till 2023
Pune, India - December 13, 2018 /MarketersMedia/ —
Hemophilia Treatment Market - Highlights:
According to the latest report published by Market Research Future (MRFR), the global market for hemophilia is set to surge at a CAGR of 6.10% between 2018 and 2023. The market is expected to reach a valuation in excess of USD 16,000 Mn by the year 2023.
Hemophilia is an inherited genetic blood disorder and holds a chronic status. People with hemophilia are likely to live with the condition throughout their life but the effects can be greatly reduced with the help of several hemophilia drug and therapeutics.
The prevalence of hemophilia has increased across the globe in recent years. A higher level of awareness and high healthcare expenditure are two major factors that are driving the growth of haemophilia treatment market in the advanced countries in Americas and Europe.
Growing used of recombinant products is also reflecting favourably on the global market for hemophilia treatment. Recombinant products are an alternative to plasma derived products and considered relatively safer.
Hemophilia drugs that are manufactured using recombinant products have proteins that are derived from genetically engineered cell lines and thereby have minimum or zero risk of contaminations. Demand for recombinant products is expected to remain high during the forecast period. Such factors are expected to support the growth of the market as well. In addition, regions such as the Middle East & Africa (MEA) and Asia Pacific (APAC) are also presenting lucrative growth opportunities to market players.
Request Sample copy at https://www.marketresearchfuture.com/sample_request/5688
Competitive Players:
Bayer AG, Swedish Orphan Biovitrum AB, Pfizer Inc, Grifols International S.A, Octapharma, Baxter, F.Hoffmann-La Roche Ltd, CSL Behring, Novo Nordisk A/S, Kedrion, Sanofi and Shire are some of the key market participants mentioned in MRFR’s report.
Regional Analysis:
Based on regions, the hemophilia treatment market has been segmented into Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA). Currently, the Americas region holds the largest share of the global haemophilia treatment market and is likely to retain its dominant position in 2018 and beyond. North America in particular present significant growth opportunities to market owing to factors such as high healthcare expenditure and existence of an advanced healthcare system. Meanwhile, Europe has emerged as the second largest market for hemophilia treatment. Presence a large number prominent drug manufacture gives the Europe market an edge. The market in APAC is also expected to witness a healthy growth during the forecast period. Rapid growth of the healthcare sector and introduction of favourable policies are attracting market players towards the region.
Segmentation:
MRFR’s report also includes an in-depth segmental analysis of the global market for haemophilia treatment based on type, treatment type, end user and region. On the basis of type, the market has been segmented into hemophilia A, hemophilia B, and hemophilia C. Of these, the hemophilia A segment will continue to hold the largest share of the market over 2023. The segment is projected to reach a valuation of more than USD 12,600 Mn towards the end of review period, reflecting a healthy CAGR. By treatment type, the market is segmented into plasma derived coagulation factor concentrate, recombinant coagulation factor concentrates, desmopressin, gene therapy and antifibrinolytic agents. The recombinant coagulation factor concentrates segment is expected to remain highly attractive during the assessment period. This is primarily owing to the high level of safety and efficacy offered by recombinant coagulation factor concentrates. In 2017, the segment stood at market valuation of USD 6,500 Mn. By end user, the market is segmented into hospitals & clinics, research organization and others. By the year 2023, the hospitals & clinics segment is expected to surpass a market valuation of USD 11,000, exhibiting an impressive CAGR of 6.53%.
Some Posits from TOC of Hemophilia Treatment Market Research Report - Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
TOC CONTINUED…
Browse Complete 158 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688
Source: MarketersMedia
Release ID: 459383
More News
Motivational Quote of the day by Sophia Loren: “I have never judged myself by other people’s standards...” — How can self-belief, personal standards and resilience help you face failure without resentment?
Today's Quote of the day by Sophia Loren explores self-belief, personal standards and the way we handle failure. Her words speak to a common struggle: comparing our lives with other people’s expectations. The lesson is simple but practical. Success feels different when we measure progress for ourselves. It also helps us face setbacks with greater responsibility, perspective and emotional strength.
Ed Sheeran calls Gaza situation 'unjustifiable' after Macklemore tour controversy
Pop star Ed Sheeran called the situation in Gaza "catastrophic and unjustifiable" during a Philadelphia concert, breaking his silence on the Israeli-Palestinian conflict. His remarks came after criticism over the removal of opening act Macklemore from his tour following the rapper's pro-Palestinian comments. Four other supporting acts later withdrew from the tour, citing their support for Palestinians.
In 1879, a French postman Ferdinand Cheval stumbled over an unusually shaped stone; 33 years later, he had built a palace in his vegetable garden
Ferdinand Cheval’s work was not immediately treated as a major artistic achievement. His creation existed outside conventional architectural movements, and he was an outsider to the established art world. Yet the Ideal Palace eventually attracted attention from influential artists, particularly figures associated with Surrealism.
Magnum wants to turn Diwali into an ice-cream festival as GLP-1 drugs reshape food demand and India could be its biggest market, says CEO
GLP-1 drugs and AI shopping will drive future food consumption globally. India, China, and the US are already experiencing these significant changes. Magnum Ice Cream is reformulating products for protein and sugar reduction. The company is investing heavily in India's growing ice cream market. India's ice cream market is expected to become Magnum's largest in the future.
German Chancellor Merz's party faces fresh setback in state elections
German Chancellor Friedrich Merz's Christian Democratic Union (CDU) faced heavy losses in two state elections, according to exit polls, adding to pressure on the leader as he struggles to revive the economy and contain the far-right AfD's rise. The AfD made gains in both states, while the CDU was projected to record its worst-ever result in Mecklenburg-Western Pomerania since World War II.
Reject US tariffs, put trade deal on hold: Congress' Anand Sharma to Govt
Congress has urged the Centre to put the proposed India-US trade deal on hold until tariff issues are resolved. Former commerce minister Anand Sharma criticised US President Donald Trump’s move to impose 100% tariffs on countries buying Russian oil, including India, calling it discriminatory and a threat to India's energy security.
Denmark says US military deal won't compromise Greenland sovereignty
Denmark and the United States have reached an agreement concerning Greenland. This deal will significantly expand the US military presence on the Arctic island. Denmark stated its sovereignty over Greenland will not be compromised by this agreement. The pact aims to prevent US adversaries from establishing bases in the territory. Key details regarding the buildup scale remain undisclosed by the parties.
Need more structural growth that stays high without policy support: Pranjul Bhandari, Chief India Economist/Strategist, Asean Economist, HSBC
"India is also at a point where goods exports may do better than they have in the past. One reason is that the currency has depreciated, making exports, especially manufactured exports, more competitive. Since early 2025, the rupee has depreciated 24% against the euro, 20% against the pound, and about 15% in real trade-weighted terms."
J&K Assembly session: Opposition to target Omar Abdullah govt over governance, reservation and statehood
The autumn session of the Jammu and Kashmir assembly kicks off on Monday, with opposition members set to challenge the government's record on various issues. Key topics include job outsourcing, corruption in public services, and concerns over unemployment and the regularization of daily wage workers. In response, the ruling National Conference is preparing strategies to meet the public's demands and concerns.
US, China open final trade talks in New York to keep tariff truce alive ahead of Trump-Xi summit
US Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng will meet Sunday in New York. They will discuss trade and other pressure points before a leader summit. Both sides aim to maintain stability in the current tariff truce. New US tariffs have been delayed until after this important meeting. This meeting seeks to prevent further escalation between the two nations.
Oil prices key external risk, but yet to derail growth outlook: Radhika Rao, Executive Director & Senior Economist, DBS Bank
"In the near term, priorities will be to manage liquidity, gradually lower the sizable forwards book and support the domestic currency. Long-end yields continue to be influenced by the hardening global yields."
ED probes TMC's ₹5.22 crore advance for aviation services
The Enforcement Directorate is examining advance payments made by Trinamool Congress for future aviation services. These payments total ₹5.22 crore and were made for services not yet availed. The agency is investigating the party's financial transactions and fund utilization through Carewell Aviation. This probe includes examining aircraft charter agreements and significant deposits made by the party. The Enforcement Directorate has also frozen six bank accounts belonging to Trinamool Congress.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.